Use of Glucostabilizer Technology in the Management of 4 Adult Intensive Care Units

Rush University Medical Center | Journal of Diabetes Science and Technology

Replacing a paper protocol with the GlucoStabilizer allowed optimal glycemic targets for different patient populations (medical ICU 140-180 mg/dL; surgical ICU 120-160 mg/dL) which allowed for lower incidence of hypoglycemia. Findings supported the concept that patients with end-stage renal disease have a modified glycemic target e.g., 160-200 mg/dL to further reduce risk of hypoglycemia.

Click below to download.